INTERNATIONAL PATENT: GLYPHIC BIOTECHNOLOGIES, INC. FILES APPLICATION FOR "NANOPORE-BASED SEQUENCING OF PEPTIDES"

GENEVA, Aug. 12 -- GLYPHIC BIOTECHNOLOGIES, INC. (169 Madison Ave. #2216New York, New York 10016) filed a patent application (PCT/US2025/013852) for "NANOPORE-BASED SEQUENCING OF PEPTIDES" on Jan 30, 2025. With publication no. WO/2025/166050, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WASSIE, Asmamaw (169 Madison Ave. #2216New York, New York 10016), ESTANDIAN, Daniel Masao (169 Madison Ave. #2216New York, New York 10016), PRICE, Andrew John (169 Madison Ave. #2216New York, New York 10016), YANG, Joshua Young Cynming ...